CTRI/2022/04/041929已完成未知
A clinical study to evaluate the efficacy of VirechanaKarma and Punarnavadi Niruha Basti along with Shamana Chikitsa in stage I and stage II chronic kidney disease
J S AYURVED MAHAVIDYALAYA0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.PATIENTS HAVING SERUM CREATININE LEVEL BETWEEN 1.4 MG/DL TO 3.0 MG/DL
- •2.PATIENTS INDICATED FOR VIRECHANA KARMA AND BASTI KARMA
排除标准
- •1.FEMALE PATIENTS HAVING PREGNANCY, BREAST FEEDING OR POST-DELIVERY PERIOD
- •2.PATIENTS OF END STAGE KIDNEY DISEASE
- •3.PATIENTS WHO ARE ON DIALYSIS TREATMENT
- •4.PATIENTS WHO HAVING PREVIOUS HISTORY OF RENAL TRANSPLANTATION
- •5.PATIENTS OF HEPATO-RENAL INSUFFICIENCY OR RENAL INSUFFICIENCY DUE TO HAEMODYNEMIC CIRCULATORY DISORDERS AND CCF
- •6.PATIENTS WITH SOME SERIOUS ILLNESS LIKE CARDIO-VASCULAR DISEASES, PSYCHOLOGICAL DISORDERS, SERIOUS ACUTE ORGANIC DISEASES, SERIOUS CHRONIC CO-MORBIDITIES, LIVER DISORDERS OR METABOLIC DISORDERS ETC
- •7.PATIENTS WITH ANY BLEEDING DISORDERS
- •8.PATIENTS CONTRAINDICATED FOR VIRECHANA KARMA AND BASTI KARMA
研究者
相似试验
尚未招募
Unknown
The study will see how virechan with Haritakyadi Modak treats obesity(sthaulya)CTRI/2024/06/069518RA Podar MedicalAyu College Worli
尚未招募
Unknown
Management of kidney disease with ayurvedic treatment.CTRI/2023/03/050945J S AYURVED MAHAVIDYALAYA
尚未招募
3 期
Effect of Kashmaryadi Kwath Virechana in treatment of Vatarakta (Gout)CTRI/2022/11/047191Dr Sarvepalli Radhakrishnan Rajasthan, Ayurved University, Jodhpur
尚未招募
2 期
Study the effect of therapeutic purgation followed by herbal formulation in the management of Non Alcoholic Fatty Liver Diseases (NAFLD)CTRI/2023/06/053635ational Institute of Ayurveda
已完成
3 期
THERAPEUTIC PURGATION IN SKIN DISEASECTRI/2021/04/032978Government PG Ayurveda College And Hospital Varanasi60